China Pharma Holdings, Inc.
CPHI
$0.82
-$0.02-2.38%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.91M | 3.99M | 4.14M | 4.05M | 4.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.91M | 3.99M | 4.14M | 4.05M | 4.40M |
| Cost of Revenue | 3.45M | 3.70M | 4.28M | 4.50M | 5.30M |
| Gross Profit | 460.20K | 289.60K | -132.00K | -443.40K | -903.30K |
| SG&A Expenses | 4.50M | 3.55M | 2.83M | 2.70M | 2.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.29M | 7.44M | 7.23M | 7.14M | 7.94M |
| Operating Income | -4.38M | -3.45M | -3.09M | -3.08M | -3.54M |
| Income Before Tax | -4.47M | -3.55M | -3.19M | -3.19M | -3.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.47 | -3.55 | -3.19 | -3.19 | -3.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.47M | -3.55M | -3.19M | -3.19M | -3.66M |
| EBIT | -4.38M | -3.45M | -3.09M | -3.08M | -3.54M |
| EBITDA | -1.44M | -1.29M | -1.58M | -1.63M | -1.75M |
| EPS Basic | -0.43 | -0.56 | -0.75 | -1.10 | -1.58 |
| Normalized Basic EPS | -0.27 | -0.35 | -0.47 | -0.69 | -0.99 |
| EPS Diluted | -0.43 | -0.56 | -0.75 | -1.10 | -1.58 |
| Normalized Diluted EPS | -0.27 | -0.35 | -0.47 | -0.69 | -0.99 |
| Average Basic Shares Outstanding | 76.76M | 39.46M | 17.12M | 12.67M | 10.53M |
| Average Diluted Shares Outstanding | 76.76M | 39.46M | 17.12M | 12.67M | 10.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |